Novo Nordisk AS (NVO)
105.06
+2.43
(+2.37%)
USD |
NYSE |
Nov 22, 16:00
105.08
+0.02
(+0.02%)
After-Hours: 20:00
Novo Nordisk Total Return Price: 105.06 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 105.06 |
November 21, 2024 | 102.63 |
November 20, 2024 | 105.27 |
November 19, 2024 | 102.63 |
November 18, 2024 | 99.81 |
November 15, 2024 | 101.74 |
November 14, 2024 | 105.32 |
November 13, 2024 | 106.91 |
November 12, 2024 | 107.06 |
November 11, 2024 | 109.09 |
November 08, 2024 | 107.20 |
November 07, 2024 | 107.63 |
November 06, 2024 | 105.36 |
November 05, 2024 | 110.13 |
November 04, 2024 | 109.72 |
November 01, 2024 | 111.94 |
October 31, 2024 | 111.95 |
October 30, 2024 | 113.24 |
October 29, 2024 | 111.98 |
October 28, 2024 | 112.36 |
October 25, 2024 | 113.38 |
October 24, 2024 | 113.92 |
October 23, 2024 | 115.74 |
October 22, 2024 | 116.47 |
October 21, 2024 | 117.33 |
Date | Value |
---|---|
October 18, 2024 | 118.09 |
October 17, 2024 | 118.22 |
October 16, 2024 | 118.03 |
October 15, 2024 | 117.81 |
October 14, 2024 | 119.78 |
October 11, 2024 | 120.04 |
October 10, 2024 | 117.53 |
October 09, 2024 | 117.00 |
October 08, 2024 | 117.20 |
October 07, 2024 | 117.77 |
October 04, 2024 | 115.12 |
October 03, 2024 | 115.08 |
October 02, 2024 | 116.48 |
October 01, 2024 | 118.01 |
September 30, 2024 | 119.07 |
September 27, 2024 | 120.76 |
September 26, 2024 | 124.30 |
September 25, 2024 | 126.95 |
September 24, 2024 | 125.44 |
September 23, 2024 | 123.70 |
September 20, 2024 | 127.51 |
September 19, 2024 | 134.88 |
September 18, 2024 | 132.06 |
September 17, 2024 | 132.00 |
September 16, 2024 | 136.90 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
22.85
Minimum
Mar 20 2020
146.36
Maximum
Jun 25 2024
64.95
Average
52.61
Median
Total Return Price Benchmarks
Ascendis Pharma AS | 129.81 |
Amgen Inc | 294.53 |
AstraZeneca PLC | 65.63 |
Viking Therapeutics Inc | 52.59 |
Evaxion Biotech AS | 1.49 |